[Effectively of combined farmaconutritive and surgical treatment of colorectal cancer].
In this article the role of immunoregulative system and cellular genome (p53 and sFAS/FASL) pathology biomarkers and oncological markers (cancer fetal antigene and CA19-9) was estimated in results of surgical treatment in complex with the various kinds of a clinical nutrition in the early postoperative period after colon cancer.
Lysenko
V G
VG
Zakharova
N B
NB
Slesarenko
S S
SS
D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000628:therapy*; D053222:Fas Ligand Protein / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015894:Genome, Human; D006801:Humans; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition / Q000379:methods*; D011182:Postoperative Care; D012189:Retrospective Studies; D019014:fas Receptor / Q000235:genetics / Q000378:metabolism*
D014408:Biomarkers, Tumor; C491901:FAS protein, human; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D019014:fas Receptor